Third-party tested Batch COA with every pen Fast UK delivery Research Use Only - Not for Human or Veterinary Use.
24/7 Customer Support
Home/Tirzepatide 40 mg Batch 07/2026: Certificate of Analysis
Batch record

Tirzepatide 40 mg Batch 07/2026: Certificate of Analysis

Independent HPLC result for Tirzepatide 40 mg, batch 07/2026: 99.304% purity, tested by Janoshik Analytical on 31 August 2026.

Last updated: November 2026

This is the public record for Tirzepatide 40 mg, batch 07/2026. The batch was tested by Janoshik Analytical, an independent laboratory that publishes every report on its own website, so you don’t have to take our word for the result.

Test result

Product Tirzepatide 40 mg pen
Batch number 07/2026
Laboratory Janoshik Analytical
Report number Task #224432
Method HPLC (high-performance liquid chromatography)
Purity 99.304%
Measured content 17.88 mg/ml
Analysis date 31 August 2026

View the original report on janoshik.com →   Download the certificate (PDF)

Tirzepatide 40 mg Pen certificate of analysis – batch 07/2026, 99.304% purity
Certificate preview. Click to open the full PDF.

Check it yourself

  1. Open the report on janoshik.com using the link above.
  2. Confirm the task number reads #224432 and the batch reads 07/2026.
  3. Compare that batch number with the one printed on your pen. They should match.

If anything doesn’t match, contact us with your order number and a photo of the label.

What the figures mean

Purity is the share of the sample that HPLC identifies as tirzepatide. 99.304% means the remaining fraction is made up of related peptide fragments and other minor components.

Measured content is the concentration of tirzepatide in the pen’s solution, in milligrams per millilitre. It is a laboratory measurement of the material, not a dose.

For a fuller walk-through, read how to read a Certificate of Analysis.

Related

Supplied strictly for laboratory research use. Not for human or veterinary use.